Nucleic Acid Therapeutics Market to Reach US$ 25.85 Billion by 2034 at a CAGR of 15.74%
Advances in gene editing technologies and RNA based innovations are transforming the development of targeted therapies across multiple disease areas. Rising investments in precision medicine and genetic research continue to strengthen the commercial landscape. Growing clinical success in gene based …